cell therapy

Manila folder with CONFIDENTIAL printed on it in red
Biotech

Capricor responds to cell therapy snub, disputes FDA’s concerns

Capricor called the rejection "difficult to understand" because the FDA had originally okayed the company's submission plan.
Darren Incorvaia Sep 9, 2025 11:44am
layoffs

Arena BioWorks, 19 months after splashy launch, lays off staff

Aug 22, 2025 10:05am
embryonic stem cells

Cell therapy biotech keeps adapting, selling 4 programs for $55M

Jul 28, 2025 10:52am
red and yellow background with scissors

Cell therapy biotech Adicet sheds 30% of staffers

Jul 24, 2025 10:20am
Graphic image of a red thumbs down against a blue background

FDA rejects Capricor’s DMD cell therapy, asks for more data

Jul 11, 2025 9:18am
ice skate on the ice

Minovia skates SPAC-wards into public market

Jun 25, 2025 10:33am